Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative.

MLA

Dengming He, et al. “Long-Term Outcomes after Nucleos(t)Ide Analogues Discontinuation in Chronic Hepatitis B Patients with HBeAg-Negative.” BMC Infectious Diseases, vol. 13, no. 1, Oct. 2013, pp. 1–7. EBSCOhost, https://doi.org/10.1186/1471-2334-13-458.

APA

Dengming He, Shimin Guo, Wen Chen, Xianli Chen, Guohua Yan, Jie Wang, Maoshi Li, Peng Zhu, Hongfei Huang, & Yuming Wang. (2013). Long-term outcomes after nucleos(t)ide analogues discontinuation in chronic hepatitis B patients with HBeAg-negative. BMC Infectious Diseases, 13(1), 1–7. https://doi.org/10.1186/1471-2334-13-458

Chicago

Dengming He, Shimin Guo, Wen Chen, Xianli Chen, Guohua Yan, Jie Wang, Maoshi Li, Peng Zhu, Hongfei Huang, and Yuming Wang. 2013. “Long-Term Outcomes after Nucleos(t)Ide Analogues Discontinuation in Chronic Hepatitis B Patients with HBeAg-Negative.” BMC Infectious Diseases 13 (1): 1–7. doi:10.1186/1471-2334-13-458.